Factor inhibiting HIF can catalyze two asparaginyl hydroxylations in VNVN motifs of ankyrin fold proteins

J Biol Chem. 2022 Jun;298(6):102020. doi: 10.1016/j.jbc.2022.102020. Epub 2022 May 7.

Abstract

The aspariginyl hydroxylase human factor inhibiting hypoxia-inducible factor (FIH) is an important regulator of the transcriptional activity of hypoxia-inducible factor. FIH also catalyzes the hydroxylation of asparaginyl and other residues in ankyrin repeat domain-containing proteins, including apoptosis stimulating of p53 protein (ASPP) family members. ASPP2 is reported to undergo a single FIH-catalyzed hydroxylation at Asn-986. We report biochemical and crystallographic evidence showing that FIH catalyzes the unprecedented post-translational hydroxylation of both asparaginyl residues in "VNVN" and related motifs of ankyrin repeat domains in ASPPs (i.e., ASPP1, ASPP2, and iASPP) and the related ASB11 and p18-INK4C proteins. Our biochemical results extend the substrate scope of FIH catalysis and may have implications for its biological roles, including in the hypoxic response and ASPP family function.

Keywords: JmjC demethylase; ankyrin; epigenetics; factor inhibiting HIF; hypoxia-inducible factor; iron and 2-oxoglutarate/alpha-ketoglutarate oxygenase; post-translational modification/hydroxylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Amino Acid Sequence
  • Ankyrin Repeat*
  • Apoptosis Regulatory Proteins
  • Catalysis
  • Humans
  • Hydroxylation
  • Hypoxia
  • Mixed Function Oxygenases* / metabolism
  • Repressor Proteins* / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Apoptosis Regulatory Proteins
  • PPP1R13B protein, human
  • Repressor Proteins
  • TP53BP2 protein, human
  • Mixed Function Oxygenases
  • HIF1AN protein, human